Nuvectis Pharma shares slide 19% on pricing of $100M stock offering
Seeking Alpha ·
Nuvectis Pharma ( NVCT ) had priced its underwritten public offering of 5M shares of its common stock at $20 per share, with expected gross proceeds of $100M, the company said Monday, sending shares down 19% in after-market trading.
DYAX Investor Sentiment
Bullish (Long) 40% · Bearish (Short) 60%
352 participants
Related News
- Germany's retail sales rise in May, beating estimates
- AI startup Tenstorrent shoots down Qualcomm buyout rumors
- Innovent, Eli Lilly partner to commercialize Verzenios in China
- Curbline Properties prices 10M share offering
- Alphabet Just Replaced Verizon in the Dow. Could Nike Be the Next Dow Stock to Be Deleted?
- Intrusion acquires VigilAigent, adding $3.5M ARR